Company officials said clinical trials for the product are in progress. Once the clinical trials are complete, Surya Vinayak Industries will file an application with the Indian Council for Medical Research (ICMR) to certify the product. It will be after the ICMR certification that the company will file a patent for the product. |
"We have drawn up plans to enter the healthcare segment. It is a well-documented fact that sandalwood has anti-bacterial, anti pyretic and other properties," said Sudhir Sharma, general manager, marketing. |
Sharma said while other drugs merely contain blood pressure, keeping it under permissible limits, sandalwood actually cures the problem without any side effect. |
"The sandalwood tablet will be a revolutionary product once it is developed," said Sharma. The pill is likely to be introduced in the market in two or three years. |
Commenting on the September-October 2004 launch of skincare products under the Lambency brand, Sharma said the company should be able to garner sales of around Rs 10 crore in the remaining part of the fiscal year. |
"We are in the process of appointing around 300 distributors across the country, who will provide Lambency products to up to 60,000 retail outlets," said Sharma. |
The company will launch face packs, scrubs and skin cream prepared in sandalwood base, along with rose water. |
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app